These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12972919)

  • 1. Botulinum neurotoxin for pharyngeal constrictor muscle spasm in tracheoesophageal voice restoration.
    Hamaker RC; Blom ED
    Laryngoscope; 2003 Sep; 113(9):1479-82. PubMed ID: 12972919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of pharyngoesophageal spasm with Botox.
    Chao SS; Graham SM; Hoffman HT
    Otolaryngol Clin North Am; 2004 Jun; 37(3):559-66. PubMed ID: 15163601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin A prolongs functional durability of voice prostheses in laryngectomees with pharyngoesophageal spasm.
    Krause E; Hempel JM; Gürkov R
    Am J Otolaryngol; 2009; 30(6):371-5. PubMed ID: 19880024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Videostroboscopy of the pharyngoesophageal segment in laryngectomy patients treated with botulinum toxin.
    Meleca RJ; Dworkin JP; Zormeier MM; Simpson ML; Shibuya T; Mathog RH
    Otolaryngol Head Neck Surg; 2000 Jul; 123(1 Pt 1):38-43. PubMed ID: 10889479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A: an effective treatment to restore phonation in laryngectomized patients unable to voice.
    Bartolomei L; Zambito Marsala S; Pighi GP; Cristofori V; Pagano G; Pontarin M; Gioulis M; Marchini C
    Neurol Sci; 2011 Jun; 32(3):443-7. PubMed ID: 21479612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary pharyngeal myotomy for tracheoesophageal speech.
    Huo J; Klastsky I; Labruna A; Weiss MH
    Ear Nose Throat J; 1995 Jun; 74(6):405-8. PubMed ID: 7628330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional outcome after surgery for prevention of pharyngospasms in tracheoesophageal speakers. Part I: Speech characteristics.
    Blom ED; Pauloski BR; Hamaker RC
    Laryngoscope; 1995 Oct; 105(10):1093-103. PubMed ID: 7564842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further experience with Botox injection for tracheoesophageal speech failure.
    Lewin JS; Bishop-Leone JK; Forman AD; Diaz EM
    Head Neck; 2001 Jun; 23(6):456-60. PubMed ID: 11360306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection of botulinum toxin for the treatment of post-laryngectomy pharyngoesophageal spasm-related disorders.
    Lightbody KA; Wilkie MD; Kinshuck AJ; Gilmartin E; Lewis-Jones H; Jones TM; Lancaster J
    Ann R Coll Surg Engl; 2015 Oct; 97(7):508-12. PubMed ID: 26414361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
    Adams SG; Hunt EJ; Charles DA; Lang AE
    J Otolaryngol; 1993 Jun; 22(3):171-5. PubMed ID: 8371328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of primary neopharyngeal repair on acoustic characteristics of tracheoesophageal voice after total laryngectomy.
    Albirmawy OA; El-Guindy AS; Elsheikh MN; Saafan ME; Darwish ME
    J Laryngol Otol; 2009 Apr; 123(4):426-33. PubMed ID: 18957154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of botulinum toxin in voice restoration after laryngectomy.
    Khemani S; Govender R; Arora A; O'Flynn PE; Vaz FM
    J Laryngol Otol; 2009 Dec; 123(12):1308-13. PubMed ID: 19607736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracheoesophageal speech failure in the laryngectomee: the role of constrictor myotomy.
    Henley J; Souliere C
    Laryngoscope; 1986 Sep; 96(9 Pt 1):1016-20. PubMed ID: 3747687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter.
    Chumpitazi BP; Fishman SJ; Nurko S
    Am J Gastroenterol; 2009 Apr; 104(4):976-83. PubMed ID: 19259081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II.
    Rubin AD; Wodchis WP; Spak C; Kileny PR; Hogikyan ND
    Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):415-20. PubMed ID: 15096423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin injection for failed tracheo-oesophageal voice in laryngectomees: the Sunderland experience.
    Ramachandran K; Arunachalam PS; Hurren A; Marsh RL; Samuel PR
    J Laryngol Otol; 2003 Jul; 117(7):544-8. PubMed ID: 12901809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
    Badarny S; Susel Z; Honigman S
    Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of myotomy of the lower constrictor in surgery of tracheo-esophageal puncture].
    Faubel Serra M; López Martínez R; Artazkoz del Toro JJ; Campos Dana JJ; Vendrell Marqués JB; Fenollosa Vázquez R
    Acta Otorrinolaringol Esp; 1992; 43(3):169-72. PubMed ID: 1515181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Botox with a Chinese type A botulinum toxin.
    Tang X; Wan X
    Chin Med J (Engl); 2000 Sep; 113(9):794-8. PubMed ID: 11776072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.